257 related articles for article (PubMed ID: 15763472)
1. Production of actinium-225 for alpha particle mediated radioimmunotherapy.
Boll RA; Malkemus D; Mirzadeh S
Appl Radiat Isot; 2005 May; 62(5):667-79. PubMed ID: 15763472
[TBL] [Abstract][Full Text] [Related]
2. Production of Ac-225 from Th-229 for targeted alpha therapy.
Apostolidis C; Molinet R; Rasmussen G; Morgenstern A
Anal Chem; 2005 Oct; 77(19):6288-91. PubMed ID: 16194090
[TBL] [Abstract][Full Text] [Related]
3. Enhanced loading efficiency and retention of 225Ac in rigid liposomes for potential targeted therapy of micrometastases.
Chang MY; Seideman J; Sofou S
Bioconjug Chem; 2008 Jun; 19(6):1274-82. PubMed ID: 18505278
[TBL] [Abstract][Full Text] [Related]
4. Engineered liposomes for potential alpha-particle therapy of metastatic cancer.
Sofou S; Thomas JL; Lin HY; McDevitt MR; Scheinberg DA; Sgouros G
J Nucl Med; 2004 Feb; 45(2):253-60. PubMed ID: 14960644
[TBL] [Abstract][Full Text] [Related]
5. Cyclotron production of Ac-225 for targeted alpha therapy.
Apostolidis C; Molinet R; McGinley J; Abbas K; Möllenbeck J; Morgenstern A
Appl Radiat Isot; 2005 Mar; 62(3):383-7. PubMed ID: 15607913
[TBL] [Abstract][Full Text] [Related]
6. A theoretical model for the production of Ac-225 for cancer therapy by photon-induced transmutation of Ra-226.
Melville G; Fan Liu S; Allen BJ
Appl Radiat Isot; 2006 Sep; 64(9):979-88. PubMed ID: 16806950
[TBL] [Abstract][Full Text] [Related]
7. Construction of a thorium/actinium generator at the Canadian Nuclear Laboratories.
Perron R; Gendron D; Causey PW
Appl Radiat Isot; 2020 Oct; 164():109262. PubMed ID: 32819503
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky MR; Pozzi OR
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates.
Miederer M; McDevitt MR; Sgouros G; Kramer K; Cheung NK; Scheinberg DA
J Nucl Med; 2004 Jan; 45(1):129-37. PubMed ID: 14734685
[TBL] [Abstract][Full Text] [Related]
10. Sterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides.
Henriksen G; Schoultz BW; Michaelsen TE; Bruland ØS; Larsen RH
Nucl Med Biol; 2004 May; 31(4):441-9. PubMed ID: 15093814
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the separation and purification of
Ivanov PI; Collins SM; van Es EM; García-Miranda M; Jerome SM; Russell BC
Appl Radiat Isot; 2017 Jun; 124():100-105. PubMed ID: 28363158
[TBL] [Abstract][Full Text] [Related]
12. Production of high-purity radium-223 from legacy actinium-beryllium neutron sources.
Soderquist CZ; McNamara BK; Fisher DR
Curr Radiopharm; 2012 Jul; 5(3):244-52. PubMed ID: 22697483
[TBL] [Abstract][Full Text] [Related]
13. Application of ion exchange and extraction chromatography to the separation of actinium from proton-irradiated thorium metal for analytical purposes.
Radchenko V; Engle JW; Wilson JJ; Maassen JR; Nortier FM; Taylor WA; Birnbaum ER; Hudston LA; John KD; Fassbender ME
J Chromatogr A; 2015 Feb; 1380():55-63. PubMed ID: 25596759
[TBL] [Abstract][Full Text] [Related]
14. LaPO4 nanoparticles doped with actinium-225 that partially sequester daughter radionuclides.
Woodward J; Kennel SJ; Stuckey A; Osborne D; Wall J; Rondinone AJ; Standaert RF; Mirzadeh S
Bioconjug Chem; 2011 Apr; 22(4):766-76. PubMed ID: 21434681
[TBL] [Abstract][Full Text] [Related]
15. Production of Ac-225 for cancer therapy by photon-induced transmutation of Ra-226.
Melville G; Meriarty H; Metcalfe P; Knittel T; Allen BJ
Appl Radiat Isot; 2007 Sep; 65(9):1014-22. PubMed ID: 17532223
[TBL] [Abstract][Full Text] [Related]
16. Targeted Alpha-Particle Therapy for Hematologic Malignancies.
Jurcic JG
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S53-S57. PubMed ID: 31253514
[TBL] [Abstract][Full Text] [Related]
17. Selective separation of radium and actinium from bulk thorium target material on strong acid cation exchange resin from sulfate media.
McAlister DR; Horwitz EP
Appl Radiat Isot; 2018 Oct; 140():18-23. PubMed ID: 29936271
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.
Song H; Hobbs RF; Vajravelu R; Huso DL; Esaias C; Apostolidis C; Morgenstern A; Sgouros G
Cancer Res; 2009 Dec; 69(23):8941-8. PubMed ID: 19920193
[TBL] [Abstract][Full Text] [Related]
19. Actinium-225 targeted alpha particle therapy for prostate cancer.
Bidkar AP; Zerefa L; Yadav S; VanBrocklin HF; Flavell RR
Theranostics; 2024; 14(7):2969-2992. PubMed ID: 38773983
[TBL] [Abstract][Full Text] [Related]
20. Development of
Ondrák L; Ondrák Fialová K; Sakmár M; Vlk M; Bruchertseifer F; Morgenstern A; Kozempel J
Nucl Med Biol; 2024; 132-133():108909. PubMed ID: 38599144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
